In this study, in addition to the international standards of ALT normalization (the WHO and AASLD criteria), the JSH criteria were also evaluated, and it was demonstrated that ALT normalization in the JSH criteria at 1 year after the start of NA therapies was associated with HCC development. This evidence concerns the gene GPT and hepatocellular carcinoma.